Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Stretching Your Dollar: What to Know About Open Enrollment 2023
What to know about open enrollment.
Stretching Your Dollar: How to Enjoy NYC This Fall on the Cheap
How to enjoy NYC without breaking the bank.
Google's Head of Search Testifies at Trial
Google's Head of Search Testifies at Trial
Exxon Profits Up From Q2, Chevron Reports Q3 Misses
Exxon Profits Up From Q2, Chevron Reports Q3 Misses
W.H. Program to Convert Commercial Buildings for Residential Use
W.H. Program to Convert Commercial Buildings for Residential Use
FTX Founder Sam Bankman-Fried Testifies Before Jury
FTX Founder Sam Bankman-Fried Testifies Before Jury
Google's Head of Search Testifies at Antitrust Trial
Google's head of search testified at the company's trial Thursday as it started presenting its defense. The Justice Department in several states alleged that Google violated antitrust law to achieve its dominance in search.
Amazon Reports Near-Record High Profit Margin
Amazon posted better-than-expected third-quarter profits with revenue up 13% over the quarter while profit margins were at a near-record high.
Stocks Mixed as Nasdaq Recovers Following Amazon Earnings
Stocks were mixed in Friday's opening session as the Nasdaq sought to recover after a rough week and following Amazon's earnings, which topped expectations.
